Artigos com autorizações de acesso público - Antonio NicolucciSaiba mais
Não disponíveis em nenhum local: 10
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin …
O Vaccaro, M Masulli, A Nicolucci, E Bonora, S Del Prato, AP Maggioni, ...
The lancet Diabetes & endocrinology 5 (11), 887-897, 2017
Autorizações: Government of Italy
Polyphenol intake and cardiovascular risk factors in a population with type 2 diabetes: The TOSCA. IT study
M Vitale, O Vaccaro, M Masulli, E Bonora, S Del Prato, CB Giorda, ...
Clinical Nutrition 36 (6), 1686-1692, 2017
Autorizações: Government of Italy
Legacy effect of intensive glucose control on major adverse cardiovascular outcome: systematic review and meta-analyses of trials according to different scenarios
F Prattichizzo, P de Candia, V De Nigris, A Nicolucci, A Ceriello
Metabolism 110, 154308, 2020
Autorizações: Government of Italy
Incidence rates and predictors of microvascular and macrovascular complications in patients with type 2 diabetes: results from the longitudinal global discover study
SV Arnold, K Khunti, F Tang, H Chen, J Cid-Ruzafa, A Cooper, P Fenici, ...
American heart journal 243, 232-239, 2022
Autorizações: National Institute for Health Research, UK
Lower risk of death and cardiovascular events in patients with diabetes initiating glucagon‐like peptide‐1 receptor agonists or sodium‐glucose cotransporter‐2 inhibitors: a …
M Baviera, S Genovese, V Lepore, P Colacioppo, F Robusto, ...
Diabetes, Obesity and Metabolism 23 (7), 1484-1495, 2021
Autorizações: Government of Italy
Occult impaired glucose regulation in patients with atherosclerosis is associated to the number of affected vascular districts and inflammation
S Rizza, M Cardellini, E Martelli, O Porzio, C Pecchioli, A Nicolucci, ...
Atherosclerosis 212 (1), 316-320, 2010
Autorizações: Fondazione Telethon, Italy
Factors associated with weight loss in people with overweight or obesity living with type 2 diabetes mellitus: Insights from the global DISCOVER study
V Hejjaji, JJ Gorgojo‐Martinez, F Tang, JB Garnelo, A Cooper, J Medina, ...
Diabetes, Obesity and Metabolism 24 (9), 1734-1740, 2022
Autorizações: US National Institutes of Health, National Institute for Health Research, UK
Health-related quality of life in patients with type 2 diabetes initiating a second-line glucose-lowering therapy: The DISCOVER study
A Nicolucci, H Chen, J Cid-Ruzafa, A Cooper, P Fenici, MB Gomes, ...
Diabetes Research and Clinical Practice 180, 108974, 2021
Autorizações: National Institute for Health Research, UK
Response to Letter to the Editor:“Cardiovascular Effects of Pioglitazone or Sulfonylureas According to Pretreatment Risk: Moving Toward Personalized Care”
O Vaccaro, A Nicolucci, G Lucisano, M Masulli, G Riccardi
The Journal of Clinical Endocrinology & Metabolism 105 (3), e909-e910, 2020
Autorizações: Government of Italy
Benefits and Risks of Aspirin Use—Reply
A Nicolucci, G De Berardis, F Pellegrini
JAMA 308 (11), 1088-1089, 2012
Autorizações: US National Institutes of Health
Disponíveis em algum local: 45
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
C Davies, H Pan, J Godwin, R Gray, R Arriagada, V Raina, M Abraham, ...
The Lancet 381 (9869), 805-816, 2013
Autorizações: Cancer Research UK
Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta …
SC Palmer, B Tendal, RA Mustafa, PO Vandvik, S Li, Q Hao, D Tunnicliffe, ...
Bmj 372, 2021
Autorizações: US National Institutes of Health
Comparison of clinical outcomes and adverse events associated with glucose-lowering drugs in patients with type 2 diabetes: a meta-analysis
SC Palmer, D Mavridis, A Nicolucci, DW Johnson, M Tonelli, JC Craig, ...
Jama 316 (3), 313-324, 2016
Autorizações: European Commission
Mobile app-based interventions to support diabetes self-management: a systematic review of randomized controlled trials to identify functions associated with glycemic efficacy
Y Wu, X Yao, G Vespasiani, A Nicolucci, Y Dong, J Kwong, L Li, X Sun, ...
JMIR mHealth and uHealth 5 (3), e6522, 2017
Autorizações: National Natural Science Foundation of China
Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study
HJL Heerspink, A Karasik, M Thuresson, C Melzer-Cohen, G Chodick, ...
The lancet Diabetes & endocrinology 8 (1), 27-35, 2020
Autorizações: National Institute for Health Research, UK
Clinical significance of nonalbuminuric renal impairment in type 2 diabetes
G Penno, A Solini, E Bonora, C Fondelli, E Orsi, G Zerbini, R Trevisan, ...
Journal of hypertension 29 (9), 1802-1809, 2011
Autorizações: US National Institutes of Health, Howard Hughes Medical Institute
Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program)
M Kosiborod, MB Gomes, A Nicolucci, S Pocock, W Rathmann, ...
Cardiovascular diabetology 17, 1-13, 2018
Autorizações: National Institute for Health Research, UK
Serum uric acid and risk of CKD in type 2 diabetes
S De Cosmo, F Viazzi, A Pacilli, C Giorda, A Ceriello, S Gentile, G Russo, ...
Clinical Journal of the American Society of Nephrology 10 (11), 1921-1929, 2015
Autorizações: US Department of Veterans Affairs
Treatment with insulin is associated with worse outcome in patients with chronic heart failure and diabetes
F Cosmi, L Shen, M Magnoli, WT Abraham, IS Anand, JG Cleland, ...
European journal of heart failure 20 (5), 888-895, 2018
Autorizações: National Institute for Health Research, UK
Treatment of type 2 diabetes mellitus worldwide: baseline patient characteristics in the global DISCOVER study
MB Gomes, W Rathmann, B Charbonnel, K Khunti, M Kosiborod, ...
Diabetes research and clinical practice 151, 20-32, 2019
Autorizações: National Institute for Health Research, UK
As informações de publicação e financiamento são determinadas automaticamente por um programa informático.